A
Anissa Viveiros
Researcher at University of Alberta
Publications - 17
Citations - 2353
Anissa Viveiros is an academic researcher from University of Alberta. The author has contributed to research in topics: Medicine & Angiotensin-converting enzyme 2. The author has an hindex of 6, co-authored 11 publications receiving 1169 citations.
Papers
More filters
Journal ArticleDOI
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
Mahmoud Gheblawi,Kaiming Wang,Anissa Viveiros,Quynh Nguyen,Jiu Chang Zhong,Anthony J. Turner,Mohan K. Raizada,Maria B. Grant,Gavin Y. Oudit +8 more
TL;DR: A review summarizes the progress over the past 20 years, highlighting the critical role of ACE2 as the novel SARS-CoV-2 receptor and as the negative regulator of the renin-angiotensin system, together with implications for the coronavirus disease 2019 pandemic and associated cardiovascular diseases.
Journal ArticleDOI
Cells of the adult human heart.
Monika Litviňuková,Monika Litviňuková,Carlos Talavera-López,Carlos Talavera-López,Henrike Maatz,Daniel Reichart,Daniel Reichart,Catherine L. Worth,Eric L. Lindberg,Masatoshi Kanda,Masatoshi Kanda,Krzysztof Polanski,Matthias Heinig,Michael Lee,Emily R. Nadelmann,Kenny Roberts,Liz Tuck,Eirini S. Fasouli,Daniel M. DeLaughter,Barbara McDonough,Barbara McDonough,Barbara McDonough,Hiroko Wakimoto,Joshua M. Gorham,Sara Samari,Krishnaa T. Mahbubani,Kourosh Saeb-Parsy,Giannino Patone,Joseph J. Boyle,Hongbo Zhang,Hongbo Zhang,Hao Zhang,Anissa Viveiros,Gavin Y. Oudit,Omer Ali Bayraktar,Jonathan G. Seidman,Christine E. Seidman,Christine E. Seidman,Christine E. Seidman,Michela Noseda,Michela Noseda,Norbert Hubner,Sarah A. Teichmann,Sarah A. Teichmann +43 more
TL;DR: The state-of-the-art analyses of large-scale single-cell and single-nucleus transcriptomes are used to construct a cellular atlas of the human heart that will aid further research into cardiac physiology and disease and provides a valuable reference for future studies.
Journal ArticleDOI
Sex Differences in COVID-19: Candidate Pathways, Genetics of ACE2, and Sex Hormones.
Anissa Viveiros,Jaslyn Rasmuson,Jennie Vu,Sharon L. Mulvagh,Sharon L. Mulvagh,Cindy Y.Y. Yip,Colleen M. Norris,Colleen M. Norris,Colleen M. Norris,Gavin Y. Oudit +9 more
TL;DR: Potential mechanisms involved in COVID-19 that may contribute to sex-specific susceptibility focusing on the innate immune system and the RAS, namely, genetics and sex hormones are explored.
Journal ArticleDOI
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies
D. B. Reichart,Eric L. Lindberg,Henrike Maatz,Antonio M. A. Miranda,Anissa Viveiros,Nikolay Shvetsov,Anna Gärtner,Emily R. Nadelmann,Michael Lee,Kazumasa Kanemaru,Jorge Ruiz-Orera,Viktoria Strohmenger,Daniel M. DeLaughter,Giannino Patone,Hao Zhang,Andrew Woehler,Christoph Lippert,Yuri Kim,Eleonora Adami,Joshua M. Gorham,Sam N. Barnett,Kemar Brown,Rachel Buchan,Rasheda A. Chowdhury,Chrystalla Constantinou,J. C. Cranley,Leanne E. Felkin,Henrik Fox,Ahla Ghauri,Jan Gummert,Masatoshi Kanda,Ruoyan Li,Lukasz Mach,Barbara McDonough,Sara Samari,Farnoush Shahriaran,Clarence Yapp,Caroline Stanasiuk,Pantazis I. Theotokis,Fabian J. Theis,Antoon J. van den Bogaerdt,Hiroaki Wakimoto,James S. Ware,Catherine L. Worth,Paul J.R. Barton,Young-Ae Lee,Sarah A. Teichmann,Hendrik Milting,Michela Noseda,Gavin Y. Oudit,Matthias Heinig,Jonathan G. Seidman,Norbert Hubner,Christine E. Seidman +53 more
TL;DR: Using single-nucleus RNA sequencing, the transcriptome of 880,000 nuclei from 18 control and 61 failing, nonischemic human hearts is characterized, illuminating both shared and distinct cellular and molecular architectures of human heart failure and suggest candidate therapeutic targets.
Journal ArticleDOI
Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease.
TL;DR: The rationale for pharmacological targeting of the perivascular and epicardial adipose tissue or associated signaling pathways as potential disease modifying approaches in cardiometabolic syndromes is highlighted.